Trademarkia Logo

Canada

C$
Trademark Search in Canada
RELINIFY

View On IC.GC.CA

RELINIFY
REGISTERED

on 24 May 2024

Last Applicant/ Owned by

Takeda Pharmaceuticals U.S.A., Inc.

500 Kendall StreetCambridge MA 02142

US

Serial Number

2217072 filed on 17th Sept 2022

Registration Number

TMA1235263 registered on 24th May 2024

Registration expiry Date

17th Sept 2032

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

RELINIFY

Trademark usage description

pharmaceuticals for use in the treatment of cancer and blood diseases and disorders medical research and information services with respect to pharmac Read More

Classification Information

Class [005]
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders

Classification kind code

11

Class [042]
Medical research and information services with respect to pharmaceuticals, oncology, and blood diseases and disorders

Classification kind code

11

Mark Details

Serial Number

2217072

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 26
on 8th Feb 2024		Approved
Submitted for opposition 27
on 8th Feb 2024		Approval Notice Sent
Submitted for opposition 22
on 2th Feb 2024		Search Recorded
Submitted for opposition 256
on 21st Aug 2023		Notification of Possible Opposition Sent
Submitted for opposition 48
on 11th Aug 2023		Agent Changed
Submitted for opposition 257
on 20th Oct 2022		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 19th Oct 2022		Created
Submitted for opposition 31
on 19th Oct 2022		Formalized
Submitted for opposition 30
on 17th Sept 2022		Filed
Submitted for opposition 228
on 17th Sept 2022		International Registration